Global BCG Vaccine Market Worth $ 0.27 Million by 2019

Date: 2016-09-11

BCG is a vaccine against tuberculosis and for the treatment of some bladder cancers. It is prepared from a strain of the attenuated live bovine tuberculosis bacillus, Mycobacterium bovis that has lost its virulence in humans. Since BCG was first used in the 1920s many different sub-strains have emerged. The various sub-strains used as vaccines are divided into two broad groups known as ‘early’ and ‘late’ strains.

Against Tuberculosis and health care is the main application of BCG vaccine product and Asia is the largest BCG vaccine market on production and consumption.

Global BCG vaccine market is projected to reach $ 0.27 Million by 2019, with a GAGR of 6.2% from 2015, and Asia will have a big dynamic momentum on the market growth. The major players in the global BCG vaccine market are Japan BCG Laboratory, Serum Institute of India Ltd, Intervax Ltd, BB-NCIPD, Statens Serum Institute etc.


Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 001-510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample